Piperonyl butoxide

CAS No. 51-03-6

Piperonyl butoxide( Piperonyl butoxide | NSC 8401 | NSC-8401 )

Catalog No. M17713 CAS No. 51-03-6

Piperonyl butoxide is an insecticide synergist, particularly for rotenone and pyrethroids.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 30 In Stock
100MG 42 In Stock
200MG 61 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Piperonyl butoxide
  • Note
    Research use only, not for human use.
  • Brief Description
    Piperonyl butoxide is an insecticide synergist, particularly for rotenone and pyrethroids.
  • Description
    Piperonyl butoxide (PBO) is an organic compound used as a component of pesticide formulations. It is a waxy white solid. It is a synergist. That is, despite having no pesticidal activity of its own, it enhances the potency of certain pesticides such as carbamates, pyrethrins, pyrethroids, and rotenone. It is a semisynthetic derivative of safrole.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Piperonyl butoxide | NSC 8401 | NSC-8401
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    MFOs
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    51-03-6
  • Formula Weight
    338.44
  • Molecular Formula
    C19H30O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 100 mg/mL. 295.47 mM;H2O : < 0.1 mg/mL
  • SMILES
    CCCCOCCOCCOCc1cc2c(OCO2)cc1CCC
  • Chemical Name
    1,3-Benzodioxole, 5-((2-(2-butoxyethoxy)ethoxy)methyl)-6-propyl-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Casida, J. E. J Agric Food Chem. 1970 Sep-Oct;18(5):753-72.
molnova catalog
related products
  • Benidipine hydrochlo...

    Benidipine HCl is a hydrochloride salt form of benidipine which is a dihydropyridine calcium channel blocker.

  • Epidermal Growth Fac...

    Epidermal Growth Factor?binds to epidermal growth factor receptor (EGFR) and stimulates cell growth and proliferation. It is approved for the treatment of diabetic foot ulcers.

  • Naquotinib

    Naquotinib (ASP-8273) is a potent, irreversible, mutant-selective inhibitor of EGFR.